Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06016946 · ClinicalTrials.gov registry record
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
A clinical trial of Friedreich Ataxia, sponsored by Friedreich's Ataxia Research Alliance.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 20
- Study locations
NCT06016946 is a study of Friedreich Ataxia that is actively recruiting participants, run by Friedreich's Ataxia Research Alliance. The registered enrollment target is 3,000 participants, above the 235-participant average among 14 other Friedreich Ataxia trials with a reported enrollment target (1177% higher). The trial reports 20 study locations across 12 states.
The verdict
NCT06016946, a study of Friedreich Ataxia, is actively recruiting participants, sponsored by Friedreich's Ataxia Research Alliance.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
This project is a global, multicenter, prospective, longitudinal, observational natural history study that can be used to understand the disease progression and support the development of safe and effective drugs and biological products for Friedreich ataxia.
Conditions Studied
Study Locations (20)
Other
- Medical University Innsbruck, Department of Neurology - Innsbruck
- Université Libre de Bruxelles, Hôpital Erasme, Dpt of Neurology - Brussels
- University of Campinas - Campinas
- Motol University Hospital, Centre for Hereditary Ataxias - Prague
- Paris Brain Institute - Paris
- Hôpital de Hautepierre, Service de Neurologie - Strasbourg
- University Hospital Aachen, Dept. of Neurology - Aachen
Florida
- University of Florida - Neurology - Gainesville
- USF Ataxia Research Center - Tampa
Quebec
- CHUM - Hopital Notre-Dame - Montreal
- McGill University Health Centre - Montreal Neurological Institute - Montreal
California
- UCLA Ataxia Center - Los Angeles
Colorado
- University of Colorado - Denver
Georgia
- Emory University Hospital - Neurology - Atlanta
Iowa
- University of Iowa, Stead Family Children's Hospital - Iowa City
Ohio
- Ohio State University - Neurology - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2023-06-28 |
| Est. Completion | 2048-01-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06016946
The ClinicalTrials.gov registry entry for NCT06016946 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 235-participant average among 14 other Friedreich Ataxia trials with a reported enrollment target (1177% higher). The listed sponsor is Friedreich's Ataxia Research Alliance, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Friedreich Ataxia appearing as the primary indexed condition, and to 0 interventions.
NCT06016946 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Other, Florida, Quebec.
Frequently Asked Questions
What is clinical trial NCT06016946 about?
NCT06016946 is a clinical study titled "Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study". This project is a global, multicenter, prospective, longitudinal, observational natural history study that can be used to understand the disease progression and support the development of safe and effective drugs and biological products for Friedreich ataxia.
What is the current status of trial NCT06016946?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2023-06-28. Estimated completion is 2048-01-28.
What conditions does trial NCT06016946 study?
This clinical trial studies the following conditions: Friedreich Ataxia.
Who is sponsoring clinical trial NCT06016946?
This trial is sponsored by Friedreich's Ataxia Research Alliance, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06016946 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Georgia, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Friedreich Ataxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Course Of Disease In Participants With FA-CM
RECRUITING
-
A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors
RECRUITING
-
A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old
RECRUITING · Phase 1
-
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
RECRUITING · Phase 1
-
A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies
RECRUITING
-
A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old (BRAVE)
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.